- Advertisement -spot_img
Wednesday, October 20, 2021

Biden Considering Robert Calif, A Former FDA Commissioner, To Lead Agency Again

WASHINGTON — The White House is looking for a candidate to head the agency once again, Dr. Robert M., a former Food and Drug Administration commissioner, according to five people familiar with the search for a candidate. Considering nominating Calif.

Since President Biden took office, the FDA has been without a permanent head, which has led to continued criticism from public health experts who have said the agency lacks clear direction during an acute phase of the pandemic. It has faced a crush of reviews of coronavirus vaccines. , testing and treatment.

People familiar with the search process said that no final decision has been taken yet. Acting FDA Commissioner, Dr. Janet Woodcock, a longtime drug regulator, is nearing the end of the period allowing acting officers to serve.

Dr Califf declined to comment. His possible nomination was first reported by The Washington Post.

Dr. Calif, a cardiologist who teaches at Duke University School of Medicine, only briefly served as FDA commissioner toward the end of President Barack Obama’s second term. He was the agency’s deputy commissioner for medical products and tobacco before heading it from February 2016 to January 2017.

He was confirmed as commissioner by the Senate in a vote of 89 to 4 in February 2016, after some lawmakers opposed his nomination, which he said was the agency’s poor record on prescription painkillers. His nomination faced severe backlash from the Democrats.

A senior federal official familiar with the administration’s finding said that Dr. Califfe was an attractive candidate for the White House because of his prior confirmation as agency commissioner, suggesting that he should go through the Senate confirmation process again. can make. Several prominent Democrats have indicated they would not support Dr. Woodcock, who has been at the FDA since 1986, if he were named as the agency’s permanent commissioner.

Read Also:  Police: Man stabbed in Rotterdam Junction on Wednesday morning, suspect arrested

Senator Joe Manchin, a West Virginia Democrat with a leading liberal vote, wrote a letter to Mr. Biden in June, criticizing Dr. Woodcock’s record in the FDA, saying he had taken opioid painkillers earlier in his career. The agency’s approval was not challenged.

“While the industry has benefited from the status quo over the past 35 years of Dr. Woodcock’s tenure at the FDA,” he wrote, “the people, patients and families suffering from the opioid epidemic have not.”

Dr. Woodcock is admired by some leaders within the FDA but his tenure as acting commissioner has been criticized several times. Earlier this year, the agency approved a new drug aducanumab for Alzheimer’s disease, a controversial decision that was opposed by the agency’s independent advisory panel and several outside scientists. In protest, several members of the panel resigned. The FDA later sought a federal investigation into the process that led to the approval.

The agency said that Dr. Woodcock was not involved in the deliberations and left the final decision on the head of the center responsible for drug applications.

Dr. Woodcock has also faced internal rebellion this year at the agency’s vaccine office, one of its major divisions. Two leaders in that office are set to leave the agency this fall; Many who heard about his decision said they were walking out of frustration with the Biden administration’s August announcement that it was planning a wider rollout of booster shots for coronavirus vaccine recipients.

Public health experts criticized the administration for pre-empting the FDA and the Centers for Disease Control and Prevention, which had not yet reviewed the shots. Dr Woodcock signed a statement announcing the plan, a move that critics said undermined its regulators.

Katie Rogers, Sharon Lafrenier And Katie Thomas Contributed to reporting.

World Nation News Deskhttps://www.worldnationnews.com
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -

Leave a Reply